In a press release issued on Tuesday, Genevant Sciences and Arbutus Biopharma announced they have entered into a global settlement with Moderna, Inc. that could result in a payment of up to $2.5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results